[1] |
Nair GB, Niederman MS. Year in review 2013: Critical care--respiratory infections[J]. Crit Care,2014,18(5):572.
|
[2] |
张娜,方春晓. 老年重症肺炎病原学特点以及预后相关因素分析[J]. 中国微生态学杂志,2019,31(9):1043-1046.
|
[3] |
刘丹,秦垚,余珍燕. 病原学筛查及C-反应蛋白,降钙素原和白细胞介素-6在小儿下呼吸道感染诊断及疗效监测中的应用[J/CD]. 中华实验和临床感染病杂志(电子版),2021,15(4):235-242.
|
[4] |
Ruiz-González A, Esquerda A, Falguera M, et al. Triggering receptor (TREM-1) expressed on myeloid cells predicts bacteremia better than clinical variables in community-acquired pneumonia[J]. Respirology,2011,16(2):321-325.
|
[5] |
Michel CS, Teschner D, Wagner EM, et al. Diagnostic value of sTREM-1, IL-8, PCT, and CRP in febrile neutropenia after autologous stem cell transplantation[J]. Ann Hematol,2017,96(12):2095-2101.
|
[6] |
Cao C, Gu J, Zhang J. Soluble triggering receptor expressed on myeloid cell-1 (sTREM-1): a potential biomarker for the diagnosis of infectious diseases[J]. Front Med,2017,11(2):169-177.
|
[7] |
Su L, Liu D, Chai W, et al. Role of sTREM-1 in predicting mortality of infection: a systematic review and meta-analysis[J]. BMJ Open,2016,6(5):e010314.
|
[8] |
刘新光,崔玉娇,王毅, 等. 肺炎链球菌血流感染患儿的生存分析及mNAP, Presepsin, TREM-1水平的早期预测价值[J]. 医学动物防制,2021,37(9):830-833.
|
[9] |
Yang ZQ, Mai JY, Zhu ML, et al. Soluble Triggering Receptors Expressed on Myeloid Cells-1 as a Neonatal Ventilator-Associated Pneumonia Biomarker[J]. Int J Gen Med,2021,14:4529-4534.
|
[10] |
瞿介明,曹彬. 中国成人社区获得性肺炎诊断和治疗指南(2016年版)修订要点[J]. 中华结核和呼吸杂志,2016,39(4):241-242.
|
[11] |
Zhang ZX, Zhang W, Liu P, et al. Prognostic value of Pneumonia Severity Index, CURB-65, CRB-65, and procalcitonin in community-acquired pneumonia in Singapore[J]. Proc Singap Healthc,2016,25(3):139-147.
|
[12] |
Martolini D, Pistella E, Carmenini E, et al. NT-proBNP correlates with the illness scores pneumonia severity index and CURB-65 in patients with pneumonia[J]. Ital J Med,2017,11(1):37-40.
|
[13] |
Niederman MS, Alder J, Bassetti M, et al. Inhaled amikacin adjunctive to intravenous standard-of-care antibiotics in mechanically ventilated patients with Gram-negative pneumonia (INHALE): a double-blind, randomised, placebo-controlled, phase 3, superiority trial[J]. Lancet Infect Dis,2020,20(3):330-340.
|
[14] |
英媛媛,徐佳傲,丁雪, 等. 不同标本留取方法对细菌培养结果的影响[J/CD]. 中华实验和临床感染病杂志(电子版),2015,9(5):657-660.
|
[15] |
文福生,张必旗,常佳军. 多指标联合检测在小儿细菌性肺炎病原学诊断中的应用[J/CD]. 中华实验和临床感染病杂志(电子版),2020,14(5):418-423.
|
[16] |
Falup-Pecurariu OG, Diez-Domingo J, Esposito S, et al. Clinical and laboratory features of children with community-acquired pneumonia are associated with distinct radiographic presentations[J]. Eur J Pediatr,2018,177(7):1111-1120.
|
[17] |
Ito A, Ishida T, Tachibana H, et al. Utility of procalcitonin for differentiating cryptogenic organising pneumonia from community-acquired pneumonia[J]. Clin Chem Lab Med (CCLM),2019,57(10):1632-1637.
|
[18] |
Póvoa P. C-reactive protein: a valuable marker of sepsis[J]. Intensive Care Med,2002,28(3):235-243.
|
[19] |
Heinrich PC, Castell JV, Andus T. Interleukin-6 and the acute phase response[J]. Biochem J,1990,265(3):621-636.
|
[20] |
Ford J W, Mcvicar D W. TREM and TREM-like receptors in inflammation and disease[J]. Curr Opin Immunol,2009,21(1):38-46.
|
[21] |
Feng JY, Su WJ, Chuang FY, et al. TREM-1 enhances Mycobacterium tuberculosis-induced inflammatory responses in macrophages[J]. Microbes Infect,2021,23(1):104765.
|
[22] |
Coimbra R. sTREM-1 as a predictor of severity and outcome in acute pancreatitis: the magic bullet or just another inflammatory mediator?[J]. Crit Care Med,2008,36(7):2197-2198.
|
[23] |
牛芳,张翠翠,唐素娟. sTREM-1, BNP, D-二聚体, PCT, IL-6在老年重症肺炎中的评估价值[J]. 临床肺科杂志,2021,26(8):1208-1211.
|
[24] |
陈一洲,陈丹琦,叶勇健, 等. 炎症因子及sTREM-1水平对骨折患者术后感染的评估价值[J]. 健康研究,2021,41(1):74-77.
|
[25] |
陈晓珊. 血清PCT, RAGE, sTREM-1表达水平与重症肺炎患者病情严重程度及预后的关系[J]. 标记免疫分析与临床,2020,27(1):136-141.
|
[26] |
郭鑫鑫. 血浆sTREM-1, sFLT-1水平与重症肺炎APACHE Ⅱ评分的关联性[J]. 牡丹江医学院学报,2021,42(1):71-74.
|
[27] |
李冀,黄奕江,吴海洪, 等. 可溶性髓样细胞触发受体1和降钙素原联合检测在重症社区获得性肺炎中的应用价值[J]. 海南医学,2017,28(11):1782-1785.
|
[28] |
杨丹榕,张云娇,徐凌, 等. 以指南和肺炎严重程度指数为标准分层确立社区获得性肺炎患者住院指征的对照分析[J]. 中华结核和呼吸杂志,2008,31(8):628.
|